CRISPR Point Mutation Cell Line Service

Catalog # :
Questions ? Contact Us

Generate physiologically relevant in vitro model with mutations seen in clinical specimens in your preferred cell lines. ASC can knock-in or correct point mutations in your gene of interest in control or disease cell lines. Very ideal for immuno-oncology research and drug discovery, our CRISPR/Cas9 cell line generation protocols can generate precise point mutations in the targeted locus.

  • CRISPR Point Mutation Cell Lines with or without silent mutation; footprint-free genome editing capable
  • Homozygous/ heterozygous variant clones
  • Variety of cell lines: cancer, hard-to-transfect, most mammalian species
  • Workflow includes:
    • gRNA design, construction, and validation
    • Donor DNA construction
    • Cell line validation, transfection and optimization
    • Screening for single cell clones and clone confirmation
    • Cell expansion and cryopreservation


  • Two homozygous clones with correct gene mutation for the modified line; two vials of each clone; 1 x 10^6 cells/vial.
  • Milestone update/report; final report with detailed description of each procedure, including targeting vector design, construction and validation, transfection condition, genotyping strategy, and results.

Timeline: 3-4 months


  • Disease modeling for immuno-oncology, pharmacogenomic studies
  • Drug discovery and drug efficacy and toxicity screening; drug combination studies
  • Deriving diagnostic reference standards and materials